Thermo Fisher Scientific (TMO) Competitors $428.25 +0.49 (+0.11%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$428.25 0.00 (0.00%) As of 07/3/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson Qiagen West Pharmaceutical Services Mettler-Toledo International Waters Thermo Fisher Scientific (NYSE:TMO) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends. Which has more volatility & risk, TMO or MEDP? Thermo Fisher Scientific has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Do analysts rate TMO or MEDP? Thermo Fisher Scientific presently has a consensus price target of $604.05, suggesting a potential upside of 41.05%. Medpace has a consensus price target of $344.82, suggesting a potential upside of 7.25%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, research analysts plainly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.80Medpace 0 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.21 Is TMO or MEDP more profitable? Medpace has a net margin of 19.31% compared to Thermo Fisher Scientific's net margin of 15.19%. Medpace's return on equity of 54.36% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.19% 17.15% 8.47% Medpace 19.31%54.36%20.81% Which has stronger valuation & earnings, TMO or MEDP? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$42.88B3.77$6.34B$17.0525.12Medpace$2.11B4.38$404.39M$13.1024.54 Do institutionals & insiders hold more shares of TMO or MEDP? 89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 20.3% of Medpace shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer TMO or MEDP? In the previous week, Thermo Fisher Scientific had 50 more articles in the media than Medpace. MarketBeat recorded 58 mentions for Thermo Fisher Scientific and 8 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.28 beat Medpace's score of 0.70 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 45 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryThermo Fisher Scientific beats Medpace on 10 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$162.07B$6.86B$5.53B$20.73BDividend Yield0.40%1.21%5.24%3.72%P/E Ratio25.1226.1527.5028.09Price / Sales3.7799.70421.0238.31Price / Cash14.3021.0936.8922.53Price / Book3.314.748.044.58Net Income$6.34B$173.18M$3.18B$986.06M7 Day Performance5.05%1.33%2.82%2.79%1 Month Performance6.09%-0.41%3.70%5.42%1 Year Performance-20.04%28.42%35.41%14.63% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.994 of 5 stars$428.25+0.1%$604.05+41.1%-20.0%$162.07B$42.88B25.12125,000Positive NewsMEDPMedpace4.454 of 5 stars$312.45+0.6%$344.82+10.4%-20.2%$8.98B$2.16B23.855,900AAgilent Technologies4.7368 of 5 stars$117.92-1.0%$140.92+19.5%-3.9%$33.50B$6.51B29.1218,100Positive NewsEx-DividendInsider TradeAMNAMN Healthcare Services4.3617 of 5 stars$20.97+0.4%$32.08+53.0%-55.6%$802.73M$2.98B-4.842,968Analyst RevisionDHRDanaher4.9411 of 5 stars$197.07-0.9%$248.61+26.2%-15.5%$141.04B$23.82B38.2763,000Positive NewsHAEHaemonetics4.8734 of 5 stars$74.92+1.5%$96.80+29.2%-8.7%$3.60B$1.36B22.633,023MCKMcKesson4.3488 of 5 stars$728.52+0.4%$696.42-4.4%+23.2%$91.15B$359.05B28.2075,000Trending NewsAnalyst RevisionQGENQiagen4.0422 of 5 stars$47.95+0.4%$49.40+3.0%+22.5%$10.66B$1.98B120.225,765Dividend AnnouncementWSTWest Pharmaceutical Services4.7576 of 5 stars$217.78-0.5%$320.00+46.9%-31.0%$15.65B$2.89B34.1910,600MTDMettler-Toledo International4.2802 of 5 stars$1,170.88-1.2%$1,300.36+11.1%-10.7%$24.33B$3.87B29.2018,000Positive NewsWATWaters4.4897 of 5 stars$348.87-1.0%$388.00+11.2%+21.9%$20.76B$2.96B31.668,200 Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives Qiagen Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
